藥 物 回 收
|
| |
| The United Kingdom: Class 2 Medicines Recall: AstraZeneca UK Limited, Bricanyl Injection, 0.5 mg／ml solution for injection or infusion (English only) |
| |
Medicines and Healthcare products Regulatory Agency (MHRA) announces that AstraZeneca UK Limited is recalling one batch of Bricanyl Injection, 0.5 mg/ml solution for injection or infusion (terbutaline sulfate) (batch number: F1029-1) as a precautionary measure due to out of specification results for a routinely tested known impurity during stability testing.
Please refer to the following website in MHRA for details:
http://www.gov.uk/drug-device-alerts/class-2-medicines-recall-astrazeneca-uk-limited-bricanyl-injection-0-dot-5-mg-slash-ml-solution-for-injection-or-infusion-pl-17901-slash-0112-el-21-a-slash-12
In Hong Kong, Bricanyl Inj 0.5mg/ml SC (HK-19618) is a pharmaceutical product registered by AstraZeneca Hong Kong Ltd (AstraZeneca), and is a prescription-only medicine. As confirmed with AstraZeneca, the affected batch has not been imported into Hong Kong.
Ends/Tuesday, May 18, 2021
Issued at HKT 15:00
|
| |
